We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$2.35B
AUM Growth
+$642M
Cap. Flow
+$723M
Cap. Flow %
30.8%
Top 10 Hldgs %
16.68%
Holding
326
New
175
Increased
123
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.3M
2
CIEN icon
Ciena
CIEN
+$17.7M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$17.5M
4
SBUX icon
Starbucks
SBUX
+$17.5M
5
BMY icon
Bristol-Myers Squibb
BMY
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 17.09%
2 Healthcare 16.22%
3 Financials 16.19%
4 Industrials 10.08%
5 Consumer Staples 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
51
NextEra Energy
NEE
$181B
$19.1M 0.81%
777,952
+175,408
+29% +$4.46M
VRNT
52
DELISTED
Verint Systems
VRNT
$19M 0.81%
614,796
-8,254
-1% -$267K
FL
53
DELISTED
Foot Locker
FL
$18.7M 0.8%
279,655
+4,595
+2% +$287K
SBUX icon
54
Starbucks
SBUX
$118B
$18.5M 0.79%
+344,800
New +$17.5M
CIEN icon
55
Ciena
CIEN
$55.3B
$18.4M 0.78%
+776,425
New +$17.7M
ALXN
56
DELISTED
Alexion Pharmaceuticals
ALXN
$18.4M 0.78%
+101,600
New +$17.5M
META icon
57
Meta Platforms (Facebook)
META
$1.5T
$18.1M 0.77%
210,941
-1,948
-0.9% -$159K
ORCL icon
58
Oracle
ORCL
$409B
$17.9M 0.76%
444,345
+132,140
+42% +$5.73M
JAZZ icon
59
Jazz Pharmaceuticals
JAZZ
$15.8B
$17.7M 0.76%
100,773
-13,284
-12% -$2.39M
BAC icon
60
Bank of America
BAC
$438B
$17.7M 0.76%
1,041,865
+160,978
+18% +$2.65M
COP icon
61
ConocoPhillips
COP
$145B
$17.5M 0.75%
285,667
+69,137
+32% +$4.51M
CSX icon
62
CSX Corp
CSX
$92.3B
$17.5M 0.75%
1,609,194
+190,965
+13% +$2.21M
CME icon
63
CME Group
CME
$95.7B
$17.5M 0.74%
187,927
+15,237
+9% +$1.42M
STZ icon
64
Constellation Brands
STZ
$22.4B
$17.5M 0.74%
150,609
-542
-0.4% -$64K
ALL icon
65
Allstate
ALL
$67.6B
$17.3M 0.73%
265,941
+33,695
+15% +$2.31M
MMM icon
66
3M
MMM
$91.4B
$17.1M 0.73%
132,458
+14,989
+13% +$2.01M
OPLN
67
Openlane
OPLN
$4.36B
$17M 0.73%
1,203,946
-1,533
-0.1% -$21.9K
PNC icon
68
PNC Financial Services
PNC
$100B
$16.9M 0.72%
176,835
+83,430
+89% +$7.89M
BMY icon
69
Bristol-Myers Squibb
BMY
$134B
$16.5M 0.7%
248,535
+229,825
+1,228% +$15.1M
SYNA icon
70
Synaptics
SYNA
$4.13B
$16.2M 0.69%
186,212
+3,037
+2% +$277K
MNST icon
71
Monster Beverage
MNST
$91.5B
$16.1M 0.69%
720,312
-54,498
-7% -$1.22M
LMT icon
72
Lockheed Martin
LMT
$135B
$16M 0.68%
85,809
-3,358
-4% -$647K
VZ icon
73
Verizon
VZ
$198B
$15.8M 0.67%
339,855
+67,011
+25% +$3.28M
HAIN icon
74
Hain Celestial
HAIN
$45.5M
$15.8M 0.67%
239,650
+50,865
+27% +$3.21M
BRK.B icon
75
Berkshire Hathaway Class B
BRK.B
$1.11T
$15.6M 0.66%
114,521
+2,813
+3% +$401K

Similar funds

Braun Stacey Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Braun Stacey Associates held 326 positions worth $2.35B, up 38% from $1.71B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Braun Stacey Associates deployed $723M of net new capital in Q2 2015, opening 175 new positions and adding to 123 existing holdings. Its largest new stake was Ciena: 776,425 shares worth $18.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Lam Research, an estimated $16.7M trimmed.

  • Braun Stacey Associates's largest Q2 2015 buy was Ciena: 776,425 shares worth $18.4M.
  • Braun Stacey Associates added most to Apple in Q2 2015, an estimated $34.3M increase.
  • Braun Stacey Associates's biggest Q2 2015 reduction was Lam Research, cutting an estimated $16.7M.
  • Braun Stacey Associates fully exited Open Text in Q2 2015, selling an estimated $14.8M.
  • Braun Stacey Associates's ten largest holdings make up 17% of its $2.35B portfolio in Q2 2015.
  • Braun Stacey Associates opened 175 new positions and closed 2 in Q2 2015.
  • Braun Stacey Associates's portfolio value rose 38% quarter-over-quarter to $2.35B.

Based on Braun Stacey Associates's 13F filing for Q2 2015, filed 18 Aug 2015.